Cardinal Health (CAH) Competitors

$103.37
+0.54 (+0.53%)
(As of 04/23/2024 ET)

CAH vs. COR, MCK, ICLR, ZBH, ALGN, RMD, ARGX, BIIB, WST, and MOH

Should you be buying Cardinal Health stock or one of its competitors? The main competitors of Cardinal Health include Cencora (COR), McKesson (MCK), ICON Public (ICLR), Zimmer Biomet (ZBH), Align Technology (ALGN), ResMed (RMD), argenx (ARGX), Biogen (BIIB), West Pharmaceutical Services (WST), and Molina Healthcare (MOH). These companies are all part of the "medical" sector.

Cardinal Health vs.

Cencora (NYSE:COR) and Cardinal Health (NYSE:CAH) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, risk, analyst recommendations, earnings, community ranking, dividends and institutional ownership.

Cencora has a net margin of 0.69% compared to Cencora's net margin of 0.30%. Cardinal Health's return on equity of 323.23% beat Cencora's return on equity.

Company Net Margins Return on Equity Return on Assets
Cencora0.69% 323.23% 4.13%
Cardinal Health 0.30%-57.44%3.89%

Cencora presently has a consensus target price of $218.22, indicating a potential downside of 8.21%. Cardinal Health has a consensus target price of $103.07, indicating a potential downside of 0.29%. Given Cencora's higher possible upside, analysts plainly believe Cardinal Health is more favorable than Cencora.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cencora
0 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.63
Cardinal Health
1 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.55

Cencora has higher revenue and earnings than Cardinal Health. Cencora is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cencora$262.17B0.18$1.75B$9.1825.90
Cardinal Health$205.01B0.12$261M$2.5440.70

Cardinal Health received 163 more outperform votes than Cencora when rated by MarketBeat users. Likewise, 71.66% of users gave Cardinal Health an outperform vote while only 65.03% of users gave Cencora an outperform vote.

CompanyUnderperformOutperform
CencoraOutperform Votes
727
65.03%
Underperform Votes
391
34.97%
Cardinal HealthOutperform Votes
890
71.66%
Underperform Votes
352
28.34%

97.5% of Cencora shares are owned by institutional investors. Comparatively, 87.2% of Cardinal Health shares are owned by institutional investors. 15.8% of Cencora shares are owned by insiders. Comparatively, 0.2% of Cardinal Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Cencora has a beta of 0.45, indicating that its share price is 55% less volatile than the S&P 500. Comparatively, Cardinal Health has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500.

In the previous week, Cardinal Health had 18 more articles in the media than Cencora. MarketBeat recorded 32 mentions for Cardinal Health and 14 mentions for Cencora. Cencora's average media sentiment score of 0.72 beat Cardinal Health's score of 0.02 indicating that Cardinal Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cencora
3 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral
Cardinal Health
12 Very Positive mention(s)
5 Positive mention(s)
6 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Positive

Cencora pays an annual dividend of $2.04 per share and has a dividend yield of 0.9%. Cardinal Health pays an annual dividend of $2.00 per share and has a dividend yield of 1.9%. Cencora pays out 22.2% of its earnings in the form of a dividend. Cardinal Health pays out 78.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Cencora has increased its dividend for 1 consecutive years and Cardinal Health has increased its dividend for 27 consecutive years. Cardinal Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Cencora beats Cardinal Health on 11 of the 21 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CAH vs. The Competition

MetricCardinal HealthDrugs, proprietaries, & sundries IndustryMedical SectorNYSE Exchange
Market Cap$25.14B$15.37B$4.84B$17.45B
Dividend Yield1.85%1.23%5.51%3.59%
P/E Ratio40.7036.06244.6425.24
Price / Sales0.122.412,531.6710.31
Price / Cash12.469.9632.1614.95
Price / Book-9.2313.184.685.01
Net Income$261M$665.71M$102.44M$963.51M
7 Day Performance-2.96%3.72%0.41%2.52%
1 Month Performance-6.88%-6.52%-5.79%-1.85%
1 Year Performance27.62%8.82%10.14%90.34%

Cardinal Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COR
Cencora
3.9378 of 5 stars
$237.73
+0.4%
$218.22
-8.2%
+42.6%$47.42B$262.17B25.9046,000Upcoming Earnings
MCK
McKesson
4.8473 of 5 stars
$531.87
+0.9%
$533.50
+0.3%
+47.8%$69.89B$276.71B24.1051,000Analyst Revision
ICLR
ICON Public
4.1338 of 5 stars
$306.45
+2.9%
$319.45
+4.2%
+48.0%$25.28B$8.12B41.5241,100
ZBH
Zimmer Biomet
4.8316 of 5 stars
$121.52
+0.6%
$139.39
+14.7%
-11.9%$24.97B$7.39B24.8518,000Analyst Revision
Positive News
ALGN
Align Technology
4.8134 of 5 stars
$311.88
+3.7%
$344.45
+10.4%
-12.2%$23.47B$3.86B53.5921,610Positive News
RMD
ResMed
4.5292 of 5 stars
$184.14
+2.1%
$199.20
+8.2%
-19.3%$27.09B$4.22B30.4410,140Upcoming Earnings
ARGX
argenx
3.8148 of 5 stars
$375.08
+1.7%
$528.16
+40.8%
-3.7%$22.29B$1.27B-72.971,148Analyst Revision
BIIB
Biogen
4.9249 of 5 stars
$193.18
-0.5%
$295.58
+53.0%
-34.3%$28.08B$9.84B24.217,570Analyst Report
WST
West Pharmaceutical Services
4.8109 of 5 stars
$389.98
+3.9%
$435.20
+11.6%
+6.6%$28.55B$2.95B49.4910,600Upcoming Earnings
MOH
Molina Healthcare
4.8225 of 5 stars
$363.22
+0.4%
$393.09
+8.2%
+31.8%$21.28B$34.07B19.34123,123

Related Companies and Tools

This page (NYSE:CAH) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners